Sign petition for Medicare coverage of Prostate Cancer treatment

The petition is linked from ustoo.org, and found on this page. Excerpt:

'I am asking the Us TOO network of survivors, family members and support group chapters to raise your voices in support of Medicare reimbursement for FDA approved cancer drugs.

On April 29, 2010, the U.S. Food and Drug Administration approved Provenge for the treatment of men with asymptomatic or minimally symptomatic metastatic, castrate resistant (hormone refractory) prostate cancer.

We celebrated the new treatment option for men with advanced disease. But now there is a problem.

Dr. Mark Moyad has brought to our attention that the agency that oversees Medicare coverage, the Centers for Medicare and Medicaid Services (CMS), wants to review the appropriateness of covering this new prostate cancer treatment.

We believe that if the FDA approves a treatment option, that Medicare and insurance companies should provide unrestricted access and coverage for it!
...
The goal is to collect thousands of signatures from across the country, so we can present them at the CMS public meeting in Baltimore on Wednesday, November 17, 2010.'